| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.052 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |